1. Home
  2. URI vs REGN Comparison

URI vs REGN Comparison

Compare URI & REGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • URI
  • REGN
  • Stock Information
  • Founded
  • URI 1997
  • REGN 1988
  • Country
  • URI United States
  • REGN United States
  • Employees
  • URI N/A
  • REGN N/A
  • Industry
  • URI Diversified Commercial Services
  • REGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • URI Consumer Discretionary
  • REGN Health Care
  • Exchange
  • URI Nasdaq
  • REGN Nasdaq
  • Market Cap
  • URI 56.8B
  • REGN 59.5B
  • IPO Year
  • URI 1997
  • REGN 1991
  • Fundamental
  • Price
  • URI $930.26
  • REGN $589.48
  • Analyst Decision
  • URI Buy
  • REGN Buy
  • Analyst Count
  • URI 12
  • REGN 22
  • Target Price
  • URI $850.33
  • REGN $806.32
  • AVG Volume (30 Days)
  • URI 498.1K
  • REGN 1.0M
  • Earning Date
  • URI 07-23-2025
  • REGN 08-01-2025
  • Dividend Yield
  • URI 0.77%
  • REGN 0.60%
  • EPS Growth
  • URI 2.05
  • REGN 5.03
  • EPS
  • URI 38.65
  • REGN 39.67
  • Revenue
  • URI $15,749,000,000.00
  • REGN $14,214,200,000.00
  • Revenue This Year
  • URI $5.43
  • REGN N/A
  • Revenue Next Year
  • URI $4.93
  • REGN $6.65
  • P/E Ratio
  • URI $24.06
  • REGN $14.86
  • Revenue Growth
  • URI 6.77
  • REGN 5.38
  • 52 Week Low
  • URI $525.91
  • REGN $476.49
  • 52 Week High
  • URI $934.51
  • REGN $1,211.20
  • Technical
  • Relative Strength Index (RSI)
  • URI 65.56
  • REGN 60.67
  • Support Level
  • URI $886.68
  • REGN $570.39
  • Resistance Level
  • URI $925.81
  • REGN $585.00
  • Average True Range (ATR)
  • URI 22.35
  • REGN 16.72
  • MACD
  • URI -1.75
  • REGN 2.93
  • Stochastic Oscillator
  • URI 91.89
  • REGN 68.39

About URI United Rentals Inc.

United Rentals is the world's largest equipment rental company, principally operating in the US and Canada. It has 16% share in a highly fragmented market serving general industrial (49%), commercial construction (46%), and residential construction (5%). The company operates a $21 billion fleet of equipment, including aerial platforms, forklifts, excavators, trucks, power generators, and various other materials serving local and national accounts from nearly 1,600 locations in North America and 100 abroad. It has pursued a strategy of bundling specialty rental capabilities to offer its customers more advanced solutions in addition to its core equipment rental business, supporting its ambitions to become a one-stop shop for customers and enhance and maintain its margin profile.

About REGN Regeneron Pharmaceuticals Inc.

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has earlier-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and Crispr-based gene editing (Intellia).

Share on Social Networks: